Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Medivir brings the Q1 webcast forward to 10 a.m. on April 30

Stockholm — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that the company will host the Q1 Quarterly Results webcast tomorrow, April 30, at 10 a.m. CET. The webcast is brought forward as Nasdaq Stockholm closes earlier.       For additional information, please contactMagnus Christensen, CFO, Medivir ABTelephone: +46 8 5468 3100E-mail: magnus.christensen@medivir.com         About Medivir Medivir develops innovative drugs with a focus

SAS TO JOIN SKY TEAM ALLIANCE

· SkyTeam and SAS, flag carrier of Scandinavia, have signed an Alliance Adherence Agreement concluding that SAS will join SkyTeam on 1 September 2024. · SAS customers will benefit from seamless products as well as enjoy more travel options to several previously unserved destinations. · All EuroBonus members will benefit from earning and burning points, while Gold and Diamond members will enjoy SkyPriority services and lounge access.AMSTERDAM/STOCKHOLM, 29 APRIL 2024 - Today marks an exciting milestone as SkyTeam and SAS have officially signed an Alliance Adherence Agreement (AAA),

Immunovia publishes the annual report for 2023

LUND, SWEDEN – Immunovia AB (publ) today announced that the Annual Report for 2023 has been published.  The annual report can be downloaded in pdf format and is available on Immunovia’s website: https://investor.immunovia.com/financial-reports-presentations/.     For more information, please contact: Karin Almqvist Liwendahl Chief Financial Officer karin.almqvist.liwendahl@immunovia.com +46 709 11 56 08   Immunovia in brief  Immunovia AB is a diagnostic company whose mission is to increase survival rates for patients with pancreatic cancer through early

Invitation to presentation in connection with EQL Pharma's year-end report, fourth quarter, 2023/24

EQL Pharma AB (publ) will publish its year-end report for the fourth quarter, 2023/24, on Tuesday, May 14[th], after stock markets closing.At 10.00 (CET) 15[th] May, the company will give a presentation via video conference. The presentation is aimed at shareholders and potential shareholders. CEO and President Axel Schörling presents and comments on the year-end report. After the presentation, there is an opportunity to ask questions for those who participate. Use the following link to access the virtual meeting: https://tinyurl.com/ysf2a9te Date and time May 15[th], 2024, at 10.

BioStock: MDR certification was Enzymatica’s highlight in Q1

Enzymatica has recently published its Q1 report, where the MDR certification for ColdZyme stands out as the key milestone during the quarter.– The MDR certification was a labor-intensive and costly process, but now that ColdZyme has been certified as one of the first cold products in Europe, it opens up great commercial opportunities.Read the full article at biostock.se : https://www.biostock.se/en/2024/04/mdr-certification-was-enzymaticas-highlight-in-q1/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Bianca Nobilo appointed Head of External Affairs at IFS

Breaking News: CNN Anchor joins IFS executive team to support AI-driven growthLondon, UK, April 29th, 2024 – IFS, the fastest growing cloud enterprise software company in the world, has today appointed former CNN News Anchor & Correspondent Bianca Nobilo as the company’s Head of External Affairs. Nobilo joins the executive leadership team at IFS to direct Government Relations, Industry Relations and External Affairs & Communications. IFS’s remarkable growth across 80 countries is fueled by the company’s powerful artificial intelligence technology, industry depth and customer centric

Cabonline Group Holding Annual Report and Sustainability Report 2023

Cabonline Group Holding´s Annual Report 2023 and Sustainability Report 2023 are now available at cabonlinegroup.com/en/about/investor/financial-reports . See also enclosed PDFs. The Swedish annual report is also available on the Group's website in the European Single Electronic Format (ESEF).For more information, please contactCharlotta Söderlund, CEO, phone +46 70 453 77 70, charlotta.weigel@cabonline.comErik Skånsberg, CFO, phone +46 79 062 38 84, erik.skansberg@cabonline.com About Cabonline GroupCabonline is the

Optomed’s January-March 2024 interim report will be published on 7 May 2024

Optomed Plc Press Release 29 April 2024 at 11.00, Helsinki Optomed’s January-March 2024 interim report  will be published on 7 May 2024 Optomed will publish its January-March 2024 interim report on 7 May 2024 approximately at 9.00 EET.   A telephone conference for analysts, investors and media will be arranged on the publishing day at 11.00 EET/10.00 CET. The event will be held in English. The presentation material will be available at www.optomed.com/investors 10.00 EET at the latest.   The participants are requested to register for the call in advance by email to sakari.

Medivir to present data for the combination of fostrox + Lenvima in HCC at ESMO GI

Stockholm — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that an abstract for the combination of fostroxacitabine bralpamide (fostrox) + Lenvima® in hepatocellular carcinoma (HCC) has been accepted for presentation at the European Society for Medical Oncology (ESMO) Gastrointestinal (GI) Cancers Congress in June 26-29, 2024 in Munich.   The abstract, titled “Liver pharmacodynamics in an open-label phase Ib/IIa study of fostroxacitabine bralpamide (fostrox, MIV-

Brain+ announces a change in its Financial Calendar for 2024

Copenhagen, Denmark, April 29, 2024 – Brain+ A/S (Nasdaq First North: BRAINP)  ·Brain+ will publish its Annual Report for 2023 on May 7, 2024   ·On April 30, 2024, the company will issue an announcement of its un-audited Annual Financial Statements for 2023Brain+ A/S (‘Brain+’ or ‘the Company’) will publish its Annual Report for 2023 on May 7, instead of on April 30, 2024, as previously stated in the Financial Calendar on the Company’s website.   The reason for the change in the publication date for Brain+’ Annual Report for 2023 is that the Company has an outstanding

OssDsign expands military access with new contract covering 100 additional VA orthopedic hospitals

Uppsala, Sweden, April 29 – OssDsign AB (publ.) today announces that the company has been awarded a new Veteran Affairs (VA) contract which covers approximately 100 additional VA orthopedic hospitals nationwide, giving OssDsign increased access to the important U.S. military market.The new contract is a continuation of OssDsign’s collaboration with Red One Medical, one of the most respected medical technology private sector representatives to the U.S. government that identifies medical innovations for the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD). The

Completion of Rights Issue – total number of shares and voting rights

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM A PART OF ANY OFFER TO SELL OR SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR SECURITIES IN THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA OR JAPAN OR IN ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Aquaporin A/S, Nymøllevej 78, DK-2800

Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

Oslo, 29 April 2024: Reference is made to the stock exchange announcement by Circio Holding ASA (OSE:CRNA) (“CIRCIO” or the “Company“) on 25 April 2024, regarding the requested conversion of convertible bonds by Atlas Special Opportunities, LLC. The share capital increase has now been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). The Company’s new share capital is NOK 4,975,682.40 divided into 8,292,804 shares, each with a nominal value of NOK 0.60.

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 97 – 29 APRIL 2024 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 96/24. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO       For further information: Stig Frederiksen, Head of

Loomis AB to publish Interim report on May 6, 2024

Loomis AB will publish the Interim report January-March 2024 on May 6, at 3:00 p.m. (CEST). Agenda Monday May 6th, 3.00 p.m. (CEST) - Report release The report will be sent as a press release from Cision (www.cision.se) and will automatically be published on www.loomis.com when released.  Tuesday May 7[th], 10.00 a.m. (CEST) – Telephone conference and audio cast Analysts and media are invited to participate in a telephone conference where Loomis President & CEO Aritz Larrea, CFO Johan Wilsby and Head of Sustainability and IR Jenny Boström will present the report and answer

STILFOLD launches MetaFold Academy with 5 MSEK in Funding to Propel Green Manufacturing in Europe

Stockholm, Sweden – MetaFold Academy, an innovative training initiative aimed at advancing green manufacturing practices within the automotive sector, has been launched this fall. Supported by a nearly 5 MSEK grant from the European Institute of Innovation and Technology (EIT) Manufacturing, MetaFold Academy is set to transform the landscape of industrial education across Sweden, Greece, Italy, and Hungary.MetaFold Academy is designed to address the urgent need for an industry-wide transition towards more sustainable practices. The project will focus on imparting skills in eco-innovation,

Volvo Car AB (publ): Contemplating new green bond issuance

Volvo Car AB (publ) ("Volvo Cars") has mandated Barclays Bank Ireland PLC, Citigroup Global Markets Europe AG, Nordea Bank Abp and Société Générale as Joint Bookrunners, to arrange a series of fixed income investor calls on 29 April 2024. A senior unsecured EUR-denominated fixed rate 6-year green bond issued under Volvo Cars’ EMTN-programme guaranteed by Volvo Car Corporation may follow, subject to market conditions. The green bond will be issued in accordance with Volvo Cars’ Green Financing Framework dated May 2023, and a second party opinion rated Dark Green has been issued by CICERO,

Comintelli Introduces New Professional Services for Competitive Intelligence

Comintelli, a leading provider of SaaS platforms for Competitive & Market Intelligence, today announced the launch of a comprehensive suite of Professional Services Packages. These services bridge the gap between strategy and execution, offering tailored support that empowers customers to maximize the value of their Competitive Intelligence (CI) initiatives.   “The need for complete CI capabilities is increasing,” says Christian Bjersér, Senior Vice President, Customer Success at Comintelli. “Businesses are recognizing the immense value of actionable insights and are seeking expert

Espiria launches a new distributing share class in response to strong performance and high demand from clients

Espiria, a part of East Capital Group, is pleased to announce the introduction of a new distributing share class in response to the exceptional performance of our Nordic Corporate Bond (NCB) fund. Surpassing expectations, within 1.5 years of inception the fund has reached an AUM (Assets Under Management) of nearly SEK 2 billion and represents almost 10% of all corporate bond flows in Sweden per Fondbolagens Förening, during this period. This new share class is designed to cater to our growing pipeline of clients and their investment needs.The new distributing share class is a unique

Genexis Group presents Q1 2024 financial report

Genexis Group’s net consolidated sales Q1 2024 were EUR 19.0 million, up by EUR 3.7 million from Q4 2023 and slightly behind the EUR 20.4 million in Q1 2023The consolidated adjusted EBITDA of Q1 was EUR 3.1 million (EUR 2.1 million Q1 2023), and the operating cash flow was positive. Operating Expenses continued to decrease during Q1, the result of the cost-reduction initiatives executed in 2023. Most of the cost synergies have now come into effect, as expected. “We see a continuous increase of our sales funnel for the year and see a large base of our smaller customers forecasting

Earnings impact of the successful listing of PPI on the Oslo Stock Exchange

Samhällsbyggnadsbolaget i Norden AB's (publ) ("SBB") associated company Public Property Invest AS ("PPI") has today been successfully listed on the Oslo Stock Exchange. The listing improved PPI's access to the capital market and is thus an important part of SBB's strategy to strengthen the group's financial position and maximise shareholder value over time. In connection with the listing, SBB transfers parts of its Norwegian portfolio to PPI. ''The listing of PPI is an important milestone in the strategic transformation that SBB is undertaking to create a decentralised group structure

SSAB and Nordec agree on deliveries of fossil-free steel

SSAB and Nordec have agreed on deliveries of fossil-free steel. Nordec will use the fossil-free steel in, for example, frame structures for buildings, façades and bridges. The agreement between SSAB and Nordec is an important step towards an efficient supply chain for fossil-free steel. SSAB aims to deliver fossil-free steel to the market in 2026 and this agreement will ensure Nordec gets the quantities of steel it needs from SSAB’s production capacity. Under the collaboration, SSAB will initially supply small quantities of fossil-free steel for the first pilot project, and in the

Nordec and SSAB agree on deliveries of fossil-free steel.

Nordec and SSAB have agreed on deliveries of fossil-free steel. Nordec will use fossil-free steel in, for example, frame structures for buildings, façades, and bridges.Nordec Group Oy press release 29.04.2024 at 09.30 EET UTC+3        Nordec and SSAB agree on deliveries of fossil-free steel. Nordec and SSAB have agreed on deliveries of fossil-free steel. Nordec will use fossil-free steel in, for example, frame structures for buildings, façades, and bridges. The agreement between Nordec and SSAB is an important step

There are no items matching the current filter
There are no more items matching the current filter
Back to top